SAVITHA BALARAMAN, MD
Medical Oncology Physician · MADISON HEIGHTS, MI
Individual Active NPI 1083696694
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 691 | 220,170 | $12,728,316 | $3,997,079 | $3,185,026 |
| 2023 | 635 | 178,820 | $9,901,925 | $3,232,187 | $2,574,004 |
| 2022 | 591 | 132,244 | $9,526,988 | $3,055,122 | $2,438,751 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1439 | Injection, ferric carboxymaltose, 1 mg | 35,250 | $1 | $1 |
| Q5110 | Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 25,020 | $0 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 11,600 | $56 | $45 |
| J1453 | Injection, fosaprepitant, 1 mg | 10,500 | $0 | $0 |
| J9267 | Injection, paclitaxel, 1 mg | 9,811 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 7,560 | $26 | $21 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 6,240 | $3 | $2 |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 5,950 | $8 | $7 |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 5,808 | $25 | $20 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 3,940 | $0 | $0 |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 3,214 | $44 | $35 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 2,370 | $1 | $1 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | 4301072119 | MI |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Michigan
- NPI 1326029265
- NPI 1578990727
- NPI 1609829001
- NPI 1417174699
- NPI 1518176296
- NPI 1659539179
- NPI 1841290491
- NPI 1487910030
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.